Exchange: NASDAQ·Updated 07:48 PM EDT

About

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Latigo Biotherapeutics Inc.?
What is the 52-week high for Latigo Biotherapeutics Inc.?
What is the 52-week low for Latigo Biotherapeutics Inc.?
What is Latigo Biotherapeutics Inc. stock price today?
What was Latigo Biotherapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of Latigo Biotherapeutics Inc.?
What is the 50-day moving average of Latigo Biotherapeutics Inc.?

Advertisement|Remove ads.